We are live on ! Find out more
EPGL

Evelyn Partners Group Ltd Portfolio holdings

AUM $46.9B
This Fund
S&P 500
This Quarter Est. Return
-2.15%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$46.9B
AUM Growth
Cap. Flow
+$5.86B
Cap. Flow %
12.5%
Top 10 Hldgs %
93.6%
Holding
551
New
551
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$421M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$409M
3
AMZN icon
Amazon
AMZN
+$395M
4
MSFT icon
Microsoft
MSFT
+$378M
5
NVDA icon
NVIDIA
NVDA
+$261M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 89.62%
2 Technology 2.91%
3 Financials 2.09%
4 Communication Services 1.32%
5 Consumer Discretionary 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPTT icon
551
Ocean Power Technologies
OPTT
$49.9M
$1 ﹤0.01%
+2
New +$1

Similar funds

Evelyn Partners Group Ltd's Q2 2026 Portfolio in Review

Q2 2026 is the first quarter with a 13F filing on record for Evelyn Partners Group Ltd, which disclosed 551 positions worth $46.9B. Its ten largest holdings account for 94% of the portfolio.

Its largest position is AstraZeneca: 2,237,205 shares worth $41.5B.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Technology and Financials.

  • Evelyn Partners Group Ltd's largest Q2 2026 buy was AstraZeneca: 2,237,205 shares worth $41.5B.
  • Evelyn Partners Group Ltd's ten largest holdings make up 94% of its $46.9B portfolio in Q2 2026.
  • Evelyn Partners Group Ltd disclosed 551 positions in Q2 2026, its first 13F filing on record.

Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.